New Results from Viz.ai Research Demonstrate Ability to Automatically Detect Suspected Large-Vessel Occlusion Stroke in Non Contrast CT Head Scans
Summary
“Earlier detection and notification of suspected LVO stroke patients using a regular CT scan will open up the opportunities for treatment,” said Raul Nogueira, MD, Professor of Neurology at Emory University and Director of Grady’s Neuroendovascular Service.“This groundbreaking research further demonstrates the opportunities that artificial intelligence can offer in helping physicians make fast stroke triage decisions thereby broadening patient access to life-changing therapies.”“Viz.ai is committed to developing novel technology to assist physicians in making faster decisions, and speed access to life saving treatment,” said Chris Mansi, Neurosurgeon and CEO of Viz.ai.Viz.ai announced its second FDA clearance for Viz CTP through the 510(k) pathway, offering healthcare providers an important tool for automated cerebral perfusion image analysis.Viz.ai is located in San Francisco and Tel Aviv and backed by leading Silicon Valley investors, including Kleiner Perkins, Google Ventures, Innovation Endeavors and DHVC.